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Serum from most young adults contains antibodies to pathogenic strains of 
meningococci (1). The strongest evidence that these antibodies are protective 
derives from the fact that resistance to meningococcal disease and the presence 
of aatimeningococcal antibodies, as determined by the serum bactericidal reac- 
tion, are closely correlated at all ages (1). Of particular importance is the ob- 
servation (2, 3) that infants in the neonatal period are highly resistant to men- 
ingococcal disease, but that they are extremely susceptible by 6 months of age. 
The curves of increasing susceptibility to systemic meningococcal infection dur- 
ing the first 6 months of life and of the development of physiological hypogam- 
maglobulinemia (4) are reciprocally rdated. 
Results of the preceding study (1) indicate that natural immunization against 
meningococcal disease occurs during childhood. Thus, between ages 2 and 12 yr 
there is a progressive increase of approximately 5 % per year in the number of 
children having serum bactericidal activity to strains of pathogenic meningo- 
cocci. In the present study, it will be shown that immune sensitization occurs, 
in large part, as a  result of the asymptomatic carriage of meningococci in the 
nasopharynx.  Group specific, cross-reactive, and  type-specific meningococcal 
antigens are seen to participate in the immunizing process. It will be further 
shown that immunity in the newborn infant is associated with the transplacental 
passage of gamma G antimeningococcal antibodies. 
Metkods 
Baa~iologi¢al Tedmiques.--Bacteriological techniques, serum bactericidal reaction, and 
indirect immunofluorescence  were performed as described  previously (1). 
Absorption of Serum and Gamma CdobuUn.--Human sera were obtained from the same 
sources as described  previously (1). 
Pooled hllrnau g~mmR globulin, Cohn fraction II, 10 mg/ml (lot No. 2191, E. R. Squibb, 
Inc., New Brunswick, N.J.), was prepared as before (1). More than 95% of the dry weight  of 
gamma globulin was IgG as determined by quantitative radial immunodiffusion  (v/de  infva). 
IgM and IgA antibodies were not detectable 0ess than 0.3% by weight). 
All absorptions were carried out at 4°C, using chilled reagents and equipment. Hemolytic 
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complement levels of serum were found to decrease less than 10% under these conditions. 
Absorptions were performed within 24 hr of the time at which the sera or gamma globulin 
preparations were to be tested. 
Absorption v.4th meningococci: 5 hr cultures of meningococci  were removed from the surface 
of the  "chocolate"  agar  medium with  a cotton  swab moistened in Dulbecco's phosphate- 
buffered saline (PBS) (5). The bacteria were washed once in PBS and added to serum in a 
ratio of one part packed bacteria (45,900 g for 15 rain) to nine parts serum, as recommended 
by Landy et at. (6). As a rule, the bacterial growth from a single Petri dish (4 inches in diame- 
ter) was used to absorb 2ml of serum. Absorption was carried out for 2 hr with frequent 
mixing of the suspension. Bacteria were removed by centrifugation, and the absorbed serum 
was sterilized by passage through a 0.45/~ Mlllipore membrane. Repeated absorptions were 
not found to be necessary. 
Absorption of gamma globulin was carried out as for serum. 
Absorption with group specific meningococcal polysaccharides: 1 rag of purified, large molecu- 
lax weight, group A or C meningococcal  polysaccharide (7) was adsorbed to 0.9 ml of alnmlnum 
hydroxyde gel (0.05 ~  AIC13 solution neutralized to pH 6.6 with NaOH).  Absorption was 
allowed to proceed for 30 rain at room temperature, by which time all of the polysaccharide 
had been removed from solution, as confirmed by capillary precipitin tests. 
I  ml of serum or pooled gamma globulin was absorbed with 100 pg of meningococcal  poly- 
saccharide (0.1 rnl of polysaccharide-alum  suspension) for 2 hr. The polysaccharide (and alum) 
was removed by centrifugation at 45,900 g for 20 rain. 
It is important to note that  alum per se removed significant amounts of complement ac- 
tivity when added to serum at 4°C, whereas alum coated with meningococcal  polysaceharide 
did not. Furthermore,  there was no nonspecific absorption of antimeningococcal antibodies 
by the polysaccharide-alum complex. 
QuanlitaIive Determination of Iramunoglobulins.--Levels of immunoglobulins G, M, and A 
in human sera were determined using the technique of quantitative radial immunodiffusion 
(8). Agar containing rabbit antibody against human IgG,  IgM, or IgA (Partigen  Plates, 
Hoechst Pharmaceutical Co., Kansas City, Mo., manufactured by Behringwerke, Marburg- 
Lahn, Germany) and pooled human serum containing known amounts of immtmoglobulins 
(standardized and stabilized human serum, Behringwerke; distributed  by Certified Blood 
Donors Service, Inc., Woodbury, N. Y.) were used in the assay. 
Hemagglulinalgon Tests.--Titration  of antibodies to meningococcal group A and C poly- 
saccharides was done by passive hemagghitination of polysaccharide-coated human erythro- 
cytes as described by Gotschlich et al. (7). 
RESULTS 
Immunity in the Adult: The Carrier State as an Immunizing Process.--Serum 
from each of 85 military  recruits (FortDix, N. J., 1966 and 1968; Fort Benning, 
Ga., 1968) was obtained before and after the recruit became a carrier of a strain 
of meningococci. 78 (92 %) of the men developed increased serum bactericidal 
activity against their own (homologous) meningococcal isolates after onset of 
the carrier state. 
Table I  records the reciprocal bactericidal titers of paired sera from 10 of the 
recruits who became carriers  of meningococci during the first 4  wk  of basic 
training. The results show that carriers of Neisseria meningitidis of serogroups 
B,  C,  and Bo  (9)  develop increased titers of bactericidal activity against the 
homologous organism. Exogenous complement was not added in these titrations, 
as a common source of complement was not available for all the meningococcal GOLDSCHNEIDER,  GOTSCHLICH~  AND  ARTENSTEIN  1329 
strains tested. It is our experience (unpublished observations) that, in unsup- 
plemented serum, complement becomes the limiting factor in serum dilutions 
of 1: 32 and above. Addition of complement to such serum frequently increases 
TABLE I 
Meningococcidal Aaivily of Sera* from Carriers of Menlngococdt 
Recruit No. 
5 
30 
32 
45 
48 
61 
64 
65 
106 
123 
Serpgroup of 
menlDgococcu8 
C 
C 
Bo 
Bo 
Bo 
B 
B 
C 
Bo 
Bo 
Reciprocal bactericidal titer of serum§ 
Day I 
4 
4 
4 
<4 
4 
4 
4 
4 
4 
4 
Day 24 
16 
8 
16 
8 
16 
16 
32 
8 
32 
32 
* D-7-2 Company, Fort Benning, Ga., 1968. 
:~ Meningococcus acquired between the 1st and 24th day of basic training. 
§ Sera from each recruit tested against his own meningococcal  isolate. 
TABLE II 
Antimeningococcal Antibodies of Immunoglobulin Classes G, M, and A in Sera* from Carriers 
of Meningococci~ 
Recruit No.  Serogroup of 
menmgococcus 
5  C 
30  C 
61  B 
64  B 
106  Bo 
123  Bo 
Day I 
4 
4 
4 
4 
4 
16 
Reciprocal immunofluorescence tltel"~ 
IgG 
Day 24 
32 
16 
16 
16 
16 
64 
IgM 
<4 
<4 
4 
4 
<4 
<4 
I~A 
Day 1  Da~  ~  Day 1  Day 24 
<4  8 
<4  8 
<4  16 
4  32 
4  8 
4  32 
* D-7-2 Company, Fort Benning, Ga., 1968. 
Meningococcus acquired between the 1st and the 24th day of basic training. 
§ Sera from each recruit tested against his own meningococcal  isolate. 
the bactericidal titer 2 to 8-fold. Thus, the bactericidal titers of some of the 24th 
day sera in Table I  are minimal values. 
Results in Table II show that the increased bactericidal activity which ac- 
companies the carrier state is associated with the production of antimeningococ- 1330  far-UNITY  TO MENINGOCOCCUS.  H 
cal antibodies. Sera from six of the meningococcal carriers in Table I were tested 
for the presence of antibodies to the homologous organisms. In every instance 
significantly  increased  titers  of  specific  IgG,  IgM,  and IgA antibodies, as 
determined by indirect immunofluorescence, were found in the 24th day serum. 
In  addition  to forming bactericidal antibodies to their own strains  of N. 
meningitidis,  carriers of meningococci also produce cross-reacting antibodies to 
heterologous strains of pathogenic meningococci. 
Table III shows the change in bactericidal activity of sera from representa- 
tive military recruits who became carriers of meningococci (serogroups C and 
TABLE  HI 
Bactericidal Activity of Sofa* from Carriers of Meningococci against Pathogenic Meningococci 
Recruit 
No. 
130 
96 
90 
219 
155 
2 
199 
Meni~ococci isolated 
from nasopharynx 
Serogroup  Day  acqmred 
Bo  3 
C  i  10-14 
C  14-20 
C  21-27 
Bo  28-35 
Noncarrier 
Sermn bactericidal titer  1:4 or greater against strain (serogroup) 
Day 1 
+ 
Day  35 
+§ 
+ 
+ 
+ 
+ 
Bll  (B) 
Dayl  l  Day3$ 
-  + 
+  + 
B 
Cll (C) 
Day 1  Day 35 
m 
A~ (A) 
b 
+ 
+ 
+ 
--  + 
+ 
+  + 
* I-2 Company, Fort Dix, N. J., 1967. 
.1: Minus sign (--); bactericidal titer less than 1:4. 
§ Plus sign (+); bactericidal titer greater than 1:4. 
Bo) during a 35 day study period. Weekly nasopharyngeal cultures were taken, 
so that the approximate date of acquisitionof the meningococcal strain is known. 
It is clear from the data that, in each instance, there was increased bactericidal 
activity to one or more of the three test strains of meningococci (groups A, B, 
and C) originally isolated from cases of meningitis. The immune response oc- 
curred within  14 days of acquisition of the carrier strain, and in recruit 155 
within 7 days of acquisition. Of 123 carriers of serogroups B, C, or Bo in four 
training companies (Fort Dix, 1966-1968) whose serum originally lacked bac- 
tericidal activity to at least one of the three pathogenic test strains, 107 (87 %) 
developed such activity after onset of the meningococcal carrier state.  27 re- 
cruits whose sera were not bactericidal to one or more of the test strains and who 
did not become carriers of meningococci during the study failed to show any 
change in spectrum of bactericidal activity. 
As in studies with homologous strains of meningococci, the development of GOLDSCHNEIDER,  GOTSCHLICH, AND  ARTENSTEIN  1331 
cross-reactive  bactericidal  activity  to  heterologous  meningococci  is  accom- 
panied by the appearance of specific IgG, IgM, and IgA antibodies, as deter- 
mined by indirect immunofluorescence.  Thus, within 2 wk of conversion from 
carrier-negative to carrier-positive status (serogroups B, C, or Bo), 15 recruits 
who were tested developed increased titers of antibodies of the three major im- 
munoglobulin classes to all the pathogenic test strains  (groups A, B, and C). 
Eight of these recruits had neither detectable bactericidal activity nor antibodies 
to one or more of the meningococcal  test strains prior to onset of the carrier 
state but developed both shortly after becoming carriers.  10 recruits who did 
not become carriers of meningococci  showed no change in pattern or titer of 
specific antibodies to meningococci. 
The dynamics of the cross-reactive immune response to the meningococcal 
carrier state was studied more closely in recruits who were cultured twice each 
week and  bled weekly for 7 wk. Results in Table IV show that the peak bac- 
tericidal titer to the heterologous test strain A1 was reached 10 to 14 days after 
conversion from a carrier-negative to a carrier-positive state (recruits  1, 3, 9, 
21, 25). This titer was maintained for the duration of the study. Recruit 18 
was a meningococcal  carrier throughout the study and maintained a constant, 
elevated bactericidal titer. In contrast, recruit 41, also a carrier for the 7 wk of 
study, showed an initial increase in titer, suggesting that he had acquired the 
meningococcal  strain shortly before the study began. Recruit 48 converted from 
a carrier-positive to a carrier-negative state at the end of the 1st wk of study. 
His elevated cross-reactive bactericidal titer remained constant over the ensuing 
6 wk. Recruit 14, who was cartier-negative during the study, showed neither in- 
crease nor decrease in bactericidal titer during the 7 wk of observation. This 
was true for sera from four other noncarriers who were studied. 
The  cross-reactive immune response induced by the meningococcal carrier 
state appears to be of long duration. Two members of our laboratory (E. W. 
and J. W.), after carrying meningococci  of serogroups B and C respectively, 
became  carrier-negative.  Elevated  cross-reactive  bactericidal  titers  against 
meningococcal  strains A1 and Bll remained constant for a minimum of 4 and 
6 months after loss of the carrier strain. Significantly,  antimeningococcal IgG 
titers remained constant during this period, while IgM and IgA levels decreased 
progressively after 4 wk. 
Immunity in the Newborn.--More  than 50 % of sera from newborn infants 
have bactericidal activity against pathogenic strains of meningococci  of sero- 
groups A, B, and C  (1). The present experiments show that this bactericidal 
activity is due to transplacental  passage of IgG  antibodies from mother  to 
fetus. 
Bactericidal activity of eight matched pairs of maternal and fetal (cord) sera 
was determined against eight pathogenic strains of meningococci  (serogroups 
A, B, C, and 135 [9]). Results in Table V show that, with only two exceptions 1332  ~txeUN1TY  TO  MENINGOCOCCUS.  II 
(both paired sera No. 3) in 64 comparisons, the spectrum of bactericidal activity 
of maternal  and fetal serum is identical. Also,  titers of bactericidal activity to 
each  organism  are generally the same for maternal  and  cord sera.  In five in- 
TABLE  IV 
Bactericidal Activity  of Sera* from Carriers of Meningococci against a Strain  of Pathogenic, 
Meningococci (A1) 
Re- 
mit 
No. 
18 
21 
25 
41 
48 
14 
Parameters measured 
Day of study 
1  3  7  10  14  17  21  24  28  31  35  38  42  45  4@ 
Carrier status~:  Bc  Bo  Bo  Bo  Bc  Bo  Bo  Bc  Bc 
Bactericidal titer§  4  4  4  4  16  1~  16  1~ 
Carrier status  --.  --  Bo  Bc  Bo  Bo  Bo  Bc  Bo  Bo  Bo  Bc 
Bactericidal titer  16  16  16  16  64  64  64  64 
Carrier status  Bc  Bo  Bo  Bo  Be 
Bactericidal titer  4  4  4  4  4  4  32  32 
Carrier status  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B 
Bactericidal titer  64  64  64  64  64  64  64  64 
Carrier status  C  C  C  C  C  C 
Bactericidal titer  4  4  4  4  4  4  32  3~ 
Carrier status  B  B  B  B  B  B  B  B  B  B  l] 
Bactericidal titer  4  4  4  1~  16  16  16  1C 
I 
Carrier status  Bo  Bo  Bc  Bo  Bo  Bo  Bc  Bo  Bo  Bo  Bo! Bo  Bo  Bo  Bc 
Bactericidal titer  16  64  64  64  64  64  64  64 
Carrier status  B  B  B  ............ 
Bactericidal titer  64  64  64  64  64  64  64  64 
Carrier status  --  --  -- 
Bactericidal titer  4  4  4  4  4  4  4  4 
* I-3 Company, Fort Dix, N. J., 1956. 
:~ Minus sign (--) indicates negative culture; letter indicates serogroup of meningococcal 
strain isolated from nasopharynx. 
§ Reciprocal bactericidal titer against meningococcal strain A1 (serogroup A). 
stances  where bactericidal  titers differed,  that of fetal  serum  was higher than 
maternal  serum. 
The  relation  of bactericidal  activity  in  fetal  serum  to  the presence  of  IgG 
antibodies was determined  by indirect immunofluorescence. In all instances in 
Table V  in which bactericidal activity was present against a  particular strain GOLDSCttNEIDER,  GOTSCIILICH~ AND  ARTENSTEIN  1333 
of meningococcus, IgG antibodies  to that  organism were detected. No  IgG 
antibodies were found when bactericidal activity was absent (i.e., bactericidal 
titer less than 1:4). Neither IgM nor IgA antibodies were detected in fetal serum 
by immunofluorescence, even when the serum was bactericidal. 
Quantitative  immunoprecipitation showed that  the  fetal sera had  6-73 % 
more immunoglobulin G than did maternal sera, a finding consistent with pub- 
lished reports (10). This presumably accounts for the tendency of the fetal sera 
to have higher bactericidal activity than the maternal sera, and for the apparent 
discrepancy in the spectra of bactericidal activity of the paired sera No. 3 in 
TABLE  V 
Bactericidal Activity of Maternal  and Fetal Sera against Pathogenic Strains  of Meningococci 
Meningococcal  strains 
(serogroup) 
A1 (A) 
129-EUR (A) 
130-EUR (B) 
153-I (B) 
166-IV  (B) 
lOT-W (c) 
Cll (C) 
122-Misc.  (135) 
1 
M~  F§ 
8  8 
4  4 
<4 <4 
8  8 
16  16 
8  8 
4  8 
16  ld 
Reciprocal bactericidal titers of paired sera* 
2 
M 
4  8 
<4  <4 
<4  <4 
<4  <4 
4  4 
>16  >16 
>16  >16 
8  8 
3  4  5 
M  F  M  F  M 
<4  4  8  8  8 
<4  <4!  4  4  4 
<4  <41 <4 <4  <4 
i 
I 
<4  41  8  8 >1~ 
<4  <4  4  4  <4 
<4 <4  4  4  4 
<4 <4  8  8  4 
<4 <4  8  8  4 
F  M  F 
16  4  4 
4 <4 <4 
<4 <4 <4 
>16  <4 <4 
<4 <4 <4 
4 <4 <4 
4 <4 <4 
4 <4 <4 
7 
M  F 
4  8 
<4 <4 
<4 <4 
4  4 
<4 <4 
4  4 
<4 <4 
<4 <4 
8 
M  F 
8 
4 
<4  <4 
16  1~ 
8  1~ 
8 
<4  <4 
16  1~ 
* Exogenous complement added. 
:~ Maternal serum. 
§ Fetal (cord) serum. 
Table V. IgM was detected in low concentration in two of eight fetal sera (9 
and 11 mg/100 ml); IgA was not found in fetal sera. 
Immunity in the Child.--After the occurrence of physiological hypogamma- 
globulinemia,  the increasing prevalence among children of bactericidal anti- 
bodies to pathogenic strains of meningococci (1) suggests that a process of ac- 
tive immunization is operative. As shown above, immune sensitization in the 
adult  occurs in response to carriage of meningococci in the nasopharynx. It 
would seem reasonable that this is a  basic mode of immunization which also 
occurs throughout childhood. The chief objection to such a hypothesis is the 
expectation that children who lack antibodies to pathogenic meningococci would 
develop systemic disease upon exposure to these organisms. Such a prediction is 
based on our study of meningococcal meningitis among military recruits (1). 
The following studies provide a possible explanation of this apparent paradox. 
Two surveys were conducted to determine the prevalence and kinds of men- 1334  IMMUNITY  TO  MENINGOCOCCUS.  11" 
ingococd carried by the children in the mid-Atlantic region of the United States. 
The results were compared with those obtained from young adult males arriving 
for basic training at Fort Dix, N. J. All surveys were conducted during spring 
and summer,  1968. Table VI shows the distribution of meningococcal strains 
within the various age groups. 55 children, ages 3 months to 6 yr, were cultured 
upon their arrival at Junior Village, Washington, D. C., a municipal home for 
orphaned and abandoned children (11). 13 of the children (23.6%) carried or- 
ganisms compatible with meningococci in the nasopharynx. Of the isolates, four 
were classical meningococci and  13 were lactose-fermenting strains (12). The 
TABLE VI 
Strains of Menlngococci Isolated from the Nasopharynx of Carriers in  Various Age Groups 
Ages* 
3 months-6 yr 
6 months-12 yr 
total children. 
19-26 yr 
No, 
cultures 
55 
137 
192 
150 
Total 
13 
23 
36 
36 
No. of menlngococcal strains isolated 
Cla~- 
ical$ 
4 
13 
17 
36 
I~c°  tose§  Typsble 
% 
9  30.8 
10  4.4 
19  13.9 
0  66.7 
Serogroups identified 
B  C  Bo 
4  0  0 
I  0  0 
Sll  o  o 
8  10  6 
* Populations studied: 3 months-6 yr, Junior Village, Washington, D. C., 1968; 6 months- 
12 yr, Walter Reed Army Medical Center, 1967; 19-26 yr, obtained from three separate 
groups of military inductees immediately  upon their arrival at Fort Dix, N. J., 1966--1968. 
:[ Ferment dextrose and maltose. 
§ Ferment dextrose, maltose, and lactose. 
[I Two classical and three lactose-fermenting  strains. 
former had typical colonial morphology, were oxidase-positive, did not grow at 
22°C, and  fermented dextrose and maltose; the latter were similar,  but fer- 
mented lactose in addition to dextrose and maltose. For convenience, the lac- 
tose-fermenting organisms will be referred to as menlngococci, although their 
relation to true meningococci has not been definitively established. Only one of 
the classical meningococci and three of the lactose-fermenting organisms were 
typable (all serogroup B). 
A survey of healthy children seen at the outpatient clinic, Walter Reed Gen- 
eral Hospital,  Washington,  D.  C.,  produced somewhat  different results,  al- 
though the trend was similar. Here the children ranged in age from 6  months 
to 12 yr, with the great majority being over 2 yr of age. As seen in Table VI, 23 
(16.8%) of 137 children studied harbored meningococci. The ratio of classical 
to lactose-fermenting strains of meningococci was 13:10. Only one typable or- GOLDSCHNEIDER, GOTSCHLICH, AND  ARTENSTErN  1335 
ganism was isolated  (serogroup B), this  being a strain  with a classical  fermenta- 
tion  pattern. 
A slmrrlation Of the meningococcal carrier  experiences of the two pediatric 
populations shows that of 192  children,  ages 3 months to 12 yr, 36 (18.8%) 
carried meningococci; 17 classical and 19 lactose-fermenting  strains. Only five 
(14 %) of the 36 isolates were typable (all group B). A similar carrier rate (24 %) 
was found among 150 military inductees (Table VI). However, in contrast to 
results of the pediatric study, there were no lactose-fermenting organisms among 
the 36 meningococcal isolates, and 67 % of the strains were typable (serogroups 
B, C, and Bo). 
Results in Table VI indicate that the population of meningococci which in- 
fants and young children acquire is different from that carried by young adults. 
It was of interest, therefore, to determine if the carriage of nontypable and lac- 
tose-fermenting  organisms produced cross-reacting antibodies to known patho- 
genic strains of meningococci. To this end 109 children at Junior Village, Wash- 
ington, D. C. were cultured every 2 wk for periods up to 4 months.  ~  The popu- 
lation under study at any point numbered approximately 60, with an average 
of five children admitted to the group and five discharged from the group every 
2 wk. According to the regulations  of the institution, all children  were  bled 
on admission, but only sporadically thereafter. Sera were stored at --20°C. 
During the study, nine children converted from carrier-negative  to carrier- 
positive status. By special permission,  serum was obtained from six of these 
children within 1 to 3 wk after acquisition  of the meningococcal strain. Table 
VII shows the cultural data and reciprocal bactericidal titers of the six children 
from whom paired sera were available.  Two of the six carriers  developed in- 
creased bactericidal activity against one or more of meningococcal strains A1, 
Bll, and Cll. Neither of the carrier strains was typable with available antisera. 
Because of the wide disparity in time between the first bleedings and acquisi- 
tion of the meningococcal strains (5 and 7 months respectively),  it was impos- 
sible to be certain that the carrier strains were indeed the cause of the increased 
bactericidal  activity in sera from the second bleedings. Therefore,  the second 
sera were absorbed  with the homologous meningococcal isolates.  In both in- 
stances the cross-reactive bactericidal  activity was removed. Hemolytic com- 
plement levels were reduced less than 10 % by these absorptions. 
Other investigators (13) have noted that, during interepidemic periods, men- 
ingococd isolated from asymptomatic carriers  among the civilian population 
are more susceptible to the bactericidal action of blood from normal adults than 
are meningococci from cases of meningitis. In the present experiments, a similar 
1  Material for this study was gathered by personnel from the Rhinovirus  Laboratory  (Dr. 
Albert Z. Kapikian,  Director), National  Institute  of Allergy  and Infectious  Diseases, National 
Institutes of Health, Bethesda, Md., as part of a continuing  survey  of infections  diseases at 
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relationship was found using  sera from children.  Two meningococcal strains 
(G-2-81 and C-52) isolated from healthy carriers were exposed to sera from the 
panel of 282 children previously tested against three case strains of meninococci 
(1). Like the case strains, the carrier strains were from adults. However, unlike 
the situation with the known pathogenic strains, where only sera from newborn 
infants and children over the age of 4 yr were bactericidal in significant num- 
bers, more than 85 % of sera from children of all ages were able to kill the two 
carrier strains in titers of 1:4 or greater. 
TABLE VII 
Meningococcoddal Activity of Sera from Children* before and after Carriage of Meningococci 
Menlngococcal isolate  Reciprocal bactericidal titerll 
Subject  Age  Serum No. 1 
L.K. 
C.W. 
N.W. 
M.H. 
L.S. 
J.A. 
yr 
2½ 
5 
2½ 
1½ 
2 
2½ 
Se~o- 
group~ 
NT 
B 
NT 
NT 
NT 
NT 
Lac- 
tose§ 
+ 
+ 
Date 
isolated 
7/22168 
7/22/68 
7122/68 
8/5/68 
9/3168 
9/3/68 
Date 
obtained  AI  Bll 
6/11/68  *(4  16 
1/10/67  <4  <4 
2/13/68  <4  *(4 
1/16/68  <4  *(4 
4/23/68  <4  <4 
2/27/68  *(4  <4 
Serum No. 25, 
ell  A1  Bll  C11 
8  *(4  16  8 
*(4  <4  <4  <4 
<4  16  32  16 
<4  <4  32  16 
<4  <4  <4  <4 
<4  <4  <4  <4 
* Junior Village, Washington, D. C., 1968. 
:~ NT, nontypable. 
§ Plus sign (+), ferments lactose in addition to dextrose and maltose. 
[[ Tested against three pathogenic strains of meningoeocci: A1 (group A), Bll (group B), 
and Cll (group C). 
¶ Obtained 7 to 21 days after isolation of meningococcal  strain. 
Antigenic Determinants of Immunity to N. meningitidis.-- 
Group-specific  antigens:  The  group-specific  meningococcal  polysaccharides 
were first isolated by Rake and Sherp (14). These polysaccharides have recently 
been isolated in large molecular weight form and chemically defined by Got- 
schlich et al. (7) and Liu et al.  u 
In  order  to determine whether group specific polysaccharides contribute to 
the immune response which accompanies the meningococcal carrier state, sera 
from 45 recruits at Fort Dix, N. J.  1967  (I-2 Company) were tested for the 
presence of antibodies  to meningococcal A  and  C  substances.  Sera were ob- 
tained during the 3rd and 8th wk of basic training.  Nasopharyngeal cultures 
were taken twice each week. Results in Fig. 1 show that 31 of 38 recruits who 
acquired a  group C meningococcus between the first and second bleedings de- 
2 Liu, T. Y., J. K. J~nsen, and E, C. Gotschlich. Manuscript in preparation. GOLDSCHNEIDER, GOTSCHLICH~ AND ARTENSTEIN  1337 
veloped increased hemagglutination titers to erythrocytes coated with C poly- 
saccharide. There was a mean increase of 16-fold in hemagglutination titer to 
the group C-specific antigen. Base line titers were 0-4 (median 0); compared 
with 4--256 (median 16) in the second serum. The immune response was detec- 
table within 2 wk of acquisition of the meningococcus. Six recruits who did not 
become carriers, and eight who carried a meningococcal strain other than sero- 
group C had no change in hemagglutination  titer to C substance. There were no 
increases in hemagglutination  titer of sera from carriers of group C meningococci 
to red blood cells coated with group A polysaccharide. 
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Fro.  1.  Distribution of change in hemagglutination titer against group C  meningococcal 
polysaccharide of sera from carriers of group C meningococci, I-2 Company, Fort Dix, N.  J. 
1967. Meningococcal strains acquired between first and second bleedings (5 wk apart).  ,,A 
Hemagglutination titer" is the number of serial 2-fold dilutions (2  n) increase or decrease  in 
reciprocal hemaggintination  titer between first and second sera. 
The relation of the rise in group-specific hemagglutination titer to the in- 
crease in bactericidal activity which accompanies the carrier state is shown in 
Table VIII. Sera obtained from recruits in I-2 Company after they acquired a 
group C meningococcus were absorbed  with meningococcal C polysaccharide. 
It is clear from the results that when anti-polysaccharide  antibodies were pre- 
sent in high titer, as detected by hemagglutiaation, these antibodies comprised 
the major part  of the bactericidal  response  against group  C  meningococci. 
When there was little antibody response to C polysaccharide  the increase in 
bactericidal  titer was considerably less and presumably due to antibodies to 
other antigens. Bactericidal titers to serogroup A (strain A1) and B (strain Bll) 
meuingococci were unaltered by absorption with C polysaccharide. 1338  IMMUNITY  TO  MENINGOCOCCUS.  H 
Some idea of the prevalence of antibodies to group-specific  meningococcal 
polysaccharides in the general population of the United States was gained by 
measuring the bactericidal activity of pooled gamma globulin (approximately 
2000 donors) before and after absorption with A and C polysaccharides. Results 
in Table IX show that the bulk of the bactericidal activity to the prototype C 
meningococcns,  (Cll), was directed against the C polysaccharide. Absorption 
of concentrated gamma globulin (10 mg/ml) with 100 #g/ml meningococcal  C 
substance reduced the bactericidal titer to strain Cll 8-fold, but did not change 
the titer against the group A organism (A1). In contrast, absorption of gamma 
TABLE  VIII 
Abso~t~n ~  Sera*from Carr~rs ~Grou~CM~i~o¢occi~  witkMeningo~Group C 
Po~suchar~e 
Reciprocal bactericidal titer§  Reciprocal hemagglutination  titer¶ 
Recruit No.  22 March  22 March 
60 
96 
184 
197 
75 
191 
15 February 
4 
4 
8 
8 
<4 
<4 
Unab~rbed  Ab~rbed[I 
256  16 
256  16 
256  32 
1024  128 
16  16 
8  4 
15 February 
Unabsorbed  Absorbedl[ 
128  4 
128  16 
256  2 
512  64 
o  0 
o  o 
* 1-2 Company, Fort Dix, N. J.,  1967. 
Meningococcal strain acquired between 15 February and 22 March. 
§ Tested against meningococcM strain Cll (group C). 
[] 100 #g group C  meuingococcal polysaccharide/ml serum. 
¶  With cells sensitized with group C polysaccharide. 
globulin with group A polysaccharide produced only a 2-fold decrease in bacte- 
ricidal activity against strain A1. This is within the range of error of the titra- 
tion, and its significance cannot be assessed.  Reabsorption with group A poly- 
saccharide was ineffective in further lowering the bactericidal titer. 
Cross-reactive antigens: The development of bactericidal antibodies to sero- 
groups of meningococci  other than that of the homologous carrier strain indi- 
cates that antigens in addition to group-specific  polysaccharides are involved 
in immune sensitization to meningococci during the carrier state. The existence 
of such antigens was further demonstrated by cross-absorption studies. 
Table X  shows the bactericidal activities of normal human serum (J. W.) 
before and after absorption with eight meningococcal  strains of various sero- 
groups.  It is clear from the results that in many instances antigens are shared 
by heterologous strains of meningococci.  Thus, all organisms  listed in Table X GOLDSCHNEIDER,  GOTSCHLICH,  AND  ARTENSTEIN  1339 
had the ability to remove bactericidal activity to one or more meningococcal 
strains. Further, most strains seemed to share at least two common antigens. 
This was shown by the ability of all strains to remove bactericidal antibodies to 
strain A1, and of all strains except A1 to absorb bactericidal  activity to strain 
130-EUR. However, none of the eight strains tested appeared to have identical 
antigenic patterns. For example, strain 70-II absorbed  bactericidal  antibodies 
to strains Bll and 130-EUR, but neither of the latter two strains completely 
removed bactericidal activity to strain 70-IL Similarly,  strain Bll removed 
bactericidal activity to  strain  130-EUR,  but  the  reciprocal  absorption was 
ineffective. 
TABLE IX 
Absorption of Pooled Human Gamma Globulin* a~itk Groups A  and  C Meningococcal 
Polysa¢charides 
Treatment of gammsL globulin 
Untreated 
Absorbed with C  (100 gg/ml) 
Absorbed with A  (100 #g/ml) 
Reciprocal bactericidal titer$ 
agtdtist meningococcal  strains 
A1 (group A) 
32 
32 
16 
CII (group C) 
64 
8 
64 
* Cohn fraction  II, 10 mg/ml.  Prepared from  blood collected  in the spring  of 1968. 
$ Exogenous complement  added. 
It could be argued that the patterns of antigenic determinants presented in 
Table X  result from incomplete  or nonspecific absorption of antibodies.  That 
this is not the case is shown by the following experiments. First, the pattern was 
reproduced  when the experiment  was repeated.  Second, reabsorption  of some 
of the aliquots of serum did not alter the pattern of bactericidal activity. Third, 
removal of bactericidal  activity to  the homologous  strain was consistently 
observed.  Fourth, absorption of another human serum (I. G.) with the same 
eight meningococeal strains produced a  similar  (although not identical)  pat- 
tern, which also was reproducible.  Finally, removal of bactericidal activity by 
absorption  with heterologous  meningococci  correlated with  the  removal  of 
antimeningococeal  antibodies as determined by indirect immunofluorescence. 
For example, absorption of the serum (J. W.) with meningococcal strain G-2-81 
removed specific IgG antibodies to strains G-2-81, A1, 70-II, Bll, and 130- 
EUR but not to strains 129-EUR, Cll, or C52. 
Antigenic determinants witkln a serogroup: Results in Table X  indicate that 
not only are there cross-reactive  antigens between the various meningococcal 
serogroups, but that antigenic variation exists within serogroups as well. An 1340  IMMUNITY  TO  MENINGOCOCCUS.  II 
attempt was made, therefore, to analyze the antigenic diversity of meningococ- 
eal strains belonging to a single serogroup. 
Table XI  summarizes an  experiment in  which  cross-absorption  of pooled 
human gamma globulin (Cohn fraction II) was carried out with 23 strains of 
serogroup C meningococci. The use of gamma globulin from a pool of approxi- 
mately 2000 adults maximized the probability of obtaining antibodies to most 
meningococcal  antigens.  Group  C  organisms were chosen  for study because 
they were most readily available. It was not desirable to rely solely on the ab- 
TABLE X 
Absorption  of Normal  Human  Serum*  with Meningococci from Diverse Serogroups 
Serum absorbed with 
meningococcal strain 
(serogroup) 
At (A) 
129-EUR (A) 
70-H 03) 
Bll (B) 
130-EUR (B) 
Clt (C) 
G-2-81 (Y) 
C-52 (NT)I[ 
Unabsorbed¶ 
Bactericidal titer 1:4 or greater against men~ococcal strains~ 
At  129-EU'R  70-II 
-§  +  + 
-  §  + 
-  +  -§ 
-  +  + 
-  +  + 
-  +  + 
--  "1-  -- 
-  +  + 
+  +  + 
BI1  130-EUR 
! 
;  ÷ 
-§  _ 
+  -§ 
+  - 
+  I  + 
C1  !  ( ~-2-81 
+  +  + 
+  +  + 
+  +  + 
+  +  + 
+  +  + 
-  +  + 
+  -§  + 
+  +  -§ 
+  + 
C-52 
+ 
* Laboratory volunteer (J. W.), male, age 23 yr, recent cartier of group C meningococci. 
:~ Minus sign (-) indicates strains to which bactericidal activity was removed (i.e., titer 
less than 1:4). Plus sign (-t-) indicates strains to which bactericidal activity was not removed 
(i.e., titer 1:4 or greater). 
§ Homologous  absorption. 
II NT, nontypable. 
¶ Original titers were 1:8 to 1:16. 
sorption with bacteria to remove all antibodies to the group C polysaccharide 
since the relative amounts of this antigen on the surface of each of the 23 menin- 
gococcal strains used for absorption was not known.  To ensure complete re- 
moval of antibodies to the group C polysacchafide, the pooled gamma globulin 
was first absorbed with purified C substance adsorbed to alum. 
The meningococci were selected to represent as diverse a collection of strains 
as possible; group C  organisms having been obtained from cases and carriers 
in civilian and military populations from Europe and widely separated areas 
of the United States during the period  1964  through  1968.  Absorptions were 
done on 2 ml aliquots of gamma globulin (10 mg/ml) for 2 hr at 4°C. Bacteri- 
cidal tests were performed in the presence of exogenous complement. Bacteri- GOLDSCHNEIDER~  GOTSCHLICH~ AND  ARTENSTEIN 
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cidal  titers  of 1:4  to  1:16 were obtained with  unabsorbed gamma  globulin 
against all  of the meningococcal  strains.  After absorption, only titers of less 
than 1:4 were considered  indicative of removal of bactericidal antibody. 
It is clear from results in Table XI that there is a spectrum of antigenic pat- 
terns among the 23 strains of group C menlngococci. At one extreme, strains 1, 
2, 3, and 4 removed bactericidal antibodies to all organisms except strains  13 
and 21; at the other extreme,  strains 22 and 23 removed bactericidal activity 
to only 9 of 23 test strains. 
In addition to the number of meningococcal  strains with which an organism 
shares common antigens,  the pattern  of absorption of bactericidal activity is 
important.  Thus,  strains  22  and  23  appeared  to be similar  antigenically  as 
judged by the fact that in addition to removing bactericidal activity to each 
other,  their absorption patterns  against the remaining  meningococcal  strains 
were identical (read horizontally in Table XI). Further, the panel of organisms 
which absorbed bactericidal activity to strains 22 and 23 was identical  (read 
vertically in Table XI).  Other organisms  which seemed to have similar pat- 
terns of surface antigens are 5 and 6, and 11 and 12. 
The remainder  of the meningococcal  strains  in Table XI,  while  obviously 
having antigens in common, differed  with regard to at least one antigen.  For 
example, most organisms  failed to remove bactericidal activity to strains  13 
and  21. However, strains  13 and  21 are not identical,  as shown by differing 
absorption patterns against organisms  3, 8, 15, and 17; and, most significantly, 
by failure of strain  13 to remove bactericidal activity to strain 21. 
The  completeness and  specificity of the absorptions were attested  by the 
facts that homologous absorptions removed bactericidal activity to each of the 
23 strains,  and that  the pattern  of bactericidal activity could be reproduced 
using the same lot of gamma globulin (half the experiment was repeated). It 
is of interest in this regard  that  strains  22 and  23 which appeared identical 
antigenically in Table XI were obtained within one month of each other from 
cases of meningitis that occurred in Frankfurt,  Germany. 
Summarizing  results  in  Table XI,  among  the  23  group  C  meningococcal 
strains tested, there appeared to be 3 pairs of antigenically identical (or closely 
related) strains and 17 nonidentical strains, judged by susceptibility to  bacte- 
ricidal  antibodies. Using the formula C  =  2"  -  1 (15),  where C equals the 
number of antigenic patterns and n  equals the number of antigenic determi- 
nants,  it is apparent  that  there are at least five antigens,  in addition to the 
group-specific  polysaccharide,  present  on  the  surface  of  group  C  meningo- 
Cocci. 
DISCUSSION 
Previous experiments have shown that susceptibility to systemic meningo- 
coccal disease, both in children and adults, is related to a deficiency of humoral C~LDSCHNEIDF_.R, GOTSCHLICH, AND A~.TENSTF--IN  1343 
antibodies to meningococci  (1). The present study describes two mechanisms 
by which such antibodies are acquired; passive immunization by transplacental 
passage of immunoglobulins,  and active sensitization as a result of the menin- 
gococcal carrier state. The effect of passively acquired immunity is obviously 
restricted to the first few months of life, but is of great theoretical importance 
for several reasons.  First,  it strongly indicates  that  humoral  antibodies are 
protective against systemic meningococcal disease.  Second, since these mater- 
nally derived antibodies are of the immunoglobulin  G class,  it would appear 
that  IgG  antibodies are  the  ones mainly  responsible for protection  against 
meningococcal disease in the adult. This is supported by the finding  that bac- 
tericidal activity could be recovered quantitatively from the IgG pool of sera 
from two adult males (one a carrier of group C meningococci,  the other normal) 
when fractionated by gel filtration on a Sephadex G-200 column (unpublished 
observations). Such immunity  would be expected to be of long duration (16). 
Third,  the protective effect of passively transferred IgG antibodies validates 
the use, in the present experiments, of pooled human gamma globulin (Cohn 
fraction  II)  to discern  the  kinds  of meningococcal  antigens  responsible  for 
elicitation of protective antibodies during the carrier state. 
The clearest demonstration  that  the meningococcal carrier state is an im- 
munizing  process is  found  among  military  recruits  in  basic training.  Here, 
acquisition of a strain of meningococci results in the production, within 2 wk 
or less,  of antibodies to meningococci.  Such antibodies are of the three major 
immunoglobulln  classes  and  combine with  group-specific  and  cross-reactive 
antigens. In military recruits and among laboratory personnd, carrier-induced 
antimeningococcal antibodies have been shown to persist at high  titer for a 
minimum of 4 to 6 months after exposure. This provides a reasonable explana- 
tion for the universal observation (17-19) that seasoned military personnd are 
much less susceptible to meningococcal disease than are basic recruits.  Such 
seasoned  troops have  apparently  been immunized  during  basic training  by 
means of the meningococcal carrier state. This is corroborated by a study (1) 
in which 65 % of a susceptible population of military recruits became carriers 
of meningococd other than the prevalent disease-producing strains.  Such in- 
dividuals  subsequently developed bactericidal  antibodies  to  the  pathogenic 
organisms (unpublished observations). 
It would appear  at first that  immunization  by the meningococcal carrier 
state, so prominent among military recruits, cannot be invoked as a mechanism 
of naturally acquired immunity in young children.  The main theoretical objec- 
tion is that children,  who lack antibodies to pathogenic strains of meningococci 
(1),  would develop systemic disease rather than become carriers of meningo- 
cocci. However, the fact is that most children become meningococcal carriers 
and not cases. As seen in the present experiments, the resolution of this paradox 
appears to be in the observation that children carry mostly atypical, nontypable 1344  I'M'~fUNITy  TO  ~IENINGOCOCCUS.  II 
strains of meningococci. Such strains have been found experimentally (20, 21) 
and epidemiologically (22, 23) to be of low virulence. 
An interesting observation was made by Fothergill and Wright (24)  which 
bears on the present findings. In a study of susceptibility of children to Hae- 
mophilus influenzae meningitis, they found that sera from most children 6 months 
to 3 yr of age were unable to kill virulent strains of H. influenzae, whereas the 
same sera routinely killed avirulent strains. We have obtained similar results 
using three meningococcal strains of proved pathogenicity and two strains from 
asymptomatic carriers.  In  addition, one of the carrier strains  (G-2-81)  was 
previously shown (1)  to be killed by sera from prospective cases of meningo- 
coccal meningitis among adults, while such sera has no effect on the pathogenic 
organisms. It is possible, therefore, although by no means proved, that menin- 
gococci isolated from asymptomatic carriers tend to be nonpathogenic because 
they are exquisitely sensitive to the bactericidal action (or other protective 
activities) of antibodies in serum. Such antibodies presumably could arise in 
the infant as a result of contact with cross-reactive antigens from nonmeningo- 
coccal sources. 
Despite  the fact that carrier strains of meningococci are generally of low 
virulence, they contain antigens which cross-react  with those of pathogenic 
meuingococci. Thus,  carrier  strains  G-2-81  and  C-52  were  able  to  remove 
bactericidal antibodies to disease-producing organisms of various serogroups. 
Furthermore, in a limited study of children, ages 2-5 yr, who converted from 
carrier-negative to carrier-positive status, two of six children developed bacte- 
ricidal antibodies which cross-reacted with one or more of the pathogenic menin- 
gococcal test strains. Absorption with the homologous carrier strain removed 
these cross-reacting antibodies. The relatively low percentage of children who 
reacted immunologically to the cartier state as compared to adults may be due 
to a  peculiarity of the immune response in children, unusual antigenicity of 
the infesting meningococci, the nature of the carrier state in children, or sampl- 
ing artifact due to the small size of the study group. It is significant in this re- 
gard that one of the children who failed to respond immunologically had ac- 
quired a classical group B meningococcus, which in the adult would be expected 
to elicit prompt production of cross-reacting antibodies. 
50 % of "meningococci" isolated from the nasopharynx of children fermented 
lactrse in addition to glucose and maltose. Such organisms have been described 
previously (12)  and were found to be indistinguishable culturally from true 
meningococci. All had been isolated from asymptomatic carriers and were pre- 
sumed to be avirulent. In our experience with several hundred strains of menin- 
gococci from cases of meningitis, none have been found to ferment lactose (un- 
published observations).  Obviously antigenic analyses and DNA homologies 
(25) are necessary to establish the identity of these lactose-fermenting Neisseria 
as meningococci. However, it was found in the present study that 4 of 19 lactose- GOLDSCHNEIDER,  GOTSCHLICH,  AND  ARTENSTEIIq  1345 
fermenting strains typed as group B meningococci.  Furthermore, many of the 
nontypable  lactose-fermenting  organisms  were  agglutinated  by antisera  to 
several meningococcal  serogroups. 
Two major groups of antigenic determinants are responsible for eliciting  the 
production 9f antibodies to meningococci:  the group-specific  polysaccharides 
and cross-reactive antigens. The presence of antibodies to group-specific  me- 
ningococcal  antigens has been described in human  sera from cases (26,  27), 
carriers  (28),  and  normal  individuals  (29).  Recent studies have shown  that 
group-specific  hemagglutinating  (30)  and  complement-fixing  (31)  antibodies 
can arise during the carrier state. The present experiments show that, in military 
recruits,  hemagglutinating  and  bactericidal  antibodies  to  purified  meningo- 
coccal C polysaccharide appear within 2 wk of acquisition of group C organisms 
in the nasopharynx. Sera from carriers  of group A meningococci were not avail- 
able for testing against the A polysaccharide. 
In order to gain some insight into the role that group-specific meningococcal 
polysaccharides play as natural immunogens in the general population, hemag- 
glutinating and bactericidal antibody titers were determined on pooled human 
gamma  globulin before and  after  absorption with  the polysaccharides.  The 
bulk of bactericidal antibodies to group C  meningococci  in gamma globulin 
collected in  1968 were directed against  the group-specific  C  polysaccharide; 
whereas little, if any, of the activity to group A organisms were directed against 
the A polysaccharide. This is not unexpected, as C organisms are prevalent in 
the United States at the present time, while group A meningococci  have been 
rare for 10 to 15 yr (32, 33). An attempt was made to demonstrate the role of 
meningococcal  A polysaccharide in natural immunity to group A organisms  by 
using a gamma globulin pool prepared in 1944, the year in which the peak of 
the last great A epidemic in the United States occurred. Unfortunately, this 
preparation of pooled gamma globulin from 1944 was totally inactive against 
meningococci  from any of the major serogroups.  It is likely that at present, 
antibodies to the meningococcal  C polysaccharide constitute a defense against 
group C organisms,  and that cross-reactive antibodies help to protect against 
group A infection. 
The  nature  of cross-reactive meningococcal  antigens  is  not known.  Such 
antigens have been recognized  since the beginning of meningococcal  research, 
being the bane of attempts to classify meningococci serologically (34--36). Cross- 
reactive antigens in other Gram-negative bacterial species such as Salmonella 
typhosa and Escherichia coli have been identified  with endotoxin (somatic or 
"O" antigens) (37, 38). It is reasonable to expect that this will prove to be the 
case with meningococci.  Indeed, preliminary reports (39)  a on purified meningo- 
coccal endotoxin suggest that common antigenic determinants may be shared 
3  Ivler, D., and F. Wyle. Personal communication. 1346  r~O~UNITY TO ~ENINGOCOCCUS.  II 
across  serogroup  lines.  We have recently found (unpublished  observations) 
complement-fixing antibodies in normal human serum to meningococcal endo- 
toxin isolated by the method of Westphal et al. (40). Also, in two of four in- 
stances, bactericidal  antibody to meningococcal strain A1 was removed  from 
human serum by absorption with endotoxin from strain A1. 
The relationship between the multiple antigenic determinants within a single 
serogroup  and  cross-reactive  antigens is not dear.  Cross-absorptive  studies 
have identified a minlmtml of five antigens in the former group.  It is possible 
that  the  antigenic determinants within  a  serogroup  are  true  type-specific 
antigens.  However,  they may be identical with the cross-reactive  antigens. 
Rake and Scherp  (41) described  a group antigen ("C" antigen)  which was 
common to the various species of the genus Neisseria.  The importance of this 
antigen has not been dearly assessed. However,  the apparent specificity and 
selectivity of bactericidal activity in human sera to individual strains of menin- 
gococci suggests that antibodies to this antigen play a minor role in natural 
immunity to meningococcal disease. 
SUMMARY 
Results of the present study suggest that natural immunity to meningococcal 
disease is initiated, reinforced, and broadened by intermittent carriage  of dif- 
ferent strains of meningococci throughout life. 
In young adults, carriage of meningococci in the nasopharynx is an efficient 
process of immune sensitization.  92 % of carriers of serogroup B, C, or Bo me- 
ningococci were found to develop increased titers of serum bactericidal activity 
to their own meningococcal isolate,  and 87 % developed  bactericidal  activity 
to heterologous  strains of pathogenic meningococci. The rise in bactericidal 
titer occurred within 2 wk of onset of the carrier state, and was accompanied by 
an increase in titer of specific IgG, IgM, and IgA antibodies to meningococci. 
In early childhood, when few children have antibodies to pathogenic menin- 
gococci, active immunization seems to occur as a result of carriage  of atypical, 
nonpathogenic strains. 
Immunity  to systemic meningococcal infection among infants in the neonatal 
period is associated with the passive  transfer of IgG antibodies from mother to 
fetus. 
The antigenic determinants which initiate the immune response to meningo- 
cocci include the group-specific C polysaccharide,  cross-reactlve antigens, and 
type-specific antigens. 
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